Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …

Weight gain is a common side effect of many widely used drugs. Weight gain of a few
kilograms to an increase of 10% or more of initial body weight has been described. Not only …

Beta-blocker (BB) therapy is a main pillar in treating patients with heart failure and reduced
ejection fraction and has shown a prognostic benefit. However, evidence for application of …

Objective A recent study observed a 2‐fold greater risk of Parkinson disease (PD) in relation
to the β2‐adrenoreceptor antagonist propranolol and a markedly lower risk of PD for the β2 …

Cardiovascular disease accounts for more than 17 million deaths globally every year, of
which complications of hypertension account for 9.4 million deaths worldwide. Early …

Abstract Background Circulating ketone bodies (KBs) are increased in patients with heart
failure (HF), corresponding with increased cardiac KB metabolism and HF severity …

Abstract Purpose of Review Current guidelines for the management of arterial hypertension
endorse β-adrenergic receptor blocking agents (beta-blockers, BBs) as being particularly …

269 essential hypertension is a common condition, affecting≈ 25% of the population1, 2
and is the leading cause of death and disability worldwide. 3 no longer viewed as a single …

Blood pressure medications are used to treat hypertension; however, low concentrations of
beta-blockers in water systems can negatively impact aquatic wildlife. Here, we conducted a …

Both calcium channel blockers (CCBs) and β blockers (BBs) are associated with fatal
substance exposures within the United States. Cases of overdose with these agents have …